Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Next Update needs to address;

<< Previous

Bullboard Posts

Next >>

Post by MirrorWorldManon Aug 31, 2022 1:09pm

198 Views

Post# 34932900

Next Update needs to address;

1)Quell concerns over increased dilution.

2)Provide revenue guidance, estimate date of promised profitability.

3)Update on R + F product launch 16 months ago and explain hiatus in revenue over last 2 quarters.

4)How long before Howie is replaced?

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market